Zobrazeno 1 - 10
of 62 344
pro vyhledávání: '"erbB-2"'
Autor:
Rathi A; From the Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Sahay A; From the Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Shet TM; From the Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Patil A; From the Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Desai SB; From the Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Publikováno v:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Apr 01; Vol. 148 (4), pp. 453-460.
Autor:
Zeme EL; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, CA., Van Loon K; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.; Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, CA., Kelley RK; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.; Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, CA., Gordan JD; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.; Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 20; Vol. 42 (27), pp. 3170-3176. Date of Electronic Publication: 2024 Aug 05.
Autor:
Shiraishi A; Div of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, 5-1-5, Kashiwanoha, Kashiwa-shi, Chiba, 277-8561, Japan., Oh-Hara T; Div of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan., Takahashi Y; Technical Research Institute, TOPPAN Holdings Inc., Japan; Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan., Uchibori K; Div of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Nishio M; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Katayama R; Div of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, 5-1-5, Kashiwanoha, Kashiwa-shi, Chiba, 277-8561, Japan. Electronic address: ryohei.katayama@jfcr.or.jp.
Publikováno v:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Sep 17; Vol. 725, pp. 150255. Date of Electronic Publication: 2024 Jun 11.
Autor:
Ye J; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.; West China School of Medicine, Sichuan University, Chengdu, China., Chen Z; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.; West China School of Medicine, Sichuan University, Chengdu, China., Liao X; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China., Wang X; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.; West China School of Medicine, Sichuan University, Chengdu, China., Zhang C; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.; West China School of Medicine, Sichuan University, Chengdu, China., Han P; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China., Wei Q; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China. weiqiang933@126.com., Bao Y; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China. yige.bao@scu.edu.cn.
Publikováno v:
World journal of urology [World J Urol] 2024 Sep 13; Vol. 42 (1), pp. 521. Date of Electronic Publication: 2024 Sep 13.
Autor:
Tobias J; Medical University of Vienna, Vienna, Austria., Maglakelidze M; ARENSIA Exploratory Medicine LLC, Tbilisi, Georgia., Andrić Z; Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia., Ryspayeva D; ARENSIA Exploratory Medicine LLC, Kyiv, Ukraine., Bulat I; ARENSIA Exploratory Medicine Research Unit, Institute of Oncology, Chisinau, Republic of Moldova., Nikolić I; Oncology Institute of Vojvodina, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia., Petrović Z; Military Medical Academy, Belgrade, Serbia., Chawla T; Tata Medical Centre, Kolkata, India., Nagarkar R; CG Manavata Cancer Centre, Nashik, India., Garner-Spitzer E; Medical University of Vienna, Vienna, Austria., Zielinski CC; Central European Cancer Center, Wiener Privatklinik, Central European Cooperative Oncology Group (CECOG), Vienna, Australia., Chong LMO; Imugene Limited, Sydney, Australia., Nixon B; Imugene Limited, Sydney, Australia., Ede NJ; Imugene Limited, Sydney, Australia., Yavrom S; Imugene Limited, Sydney, Australia., Kundi M; Medical University of Vienna, Vienna, Austria., Wiedermann U; Medical University of Vienna, Vienna, Austria.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 13; Vol. 30 (18), pp. 4044-4054.
Autor:
Iida N; Translational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan., Imai M; Translational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan., Okamoto W; Department of Clinical Oncology, Hiroshima University Hospital, Hiroshima, Japan., Kato T; Department of Surgery, NHO Osaka National Hospital, Osaka, Japan., Esaki T; Department of Gastrointestinal and Medical Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan., Kato K; Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Komatsu Y; Department of Cancer Center, Hokkaido University Hospital, Sapporo, Japan., Yuki S; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan., Masuishi T; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Nishina T; Gastrointestinal Medical Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan., Ebi H; Division of Molecular Therapeutics, Aichi Cancer Center Research Institute, Nagoya, Japan., Taniguchi H; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Nonomura N; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Japan., Sunakawa Y; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan., Shiozawa M; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan., Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shunto-gun, Japan., Boku S; Cancer Treatment Center, Kansai Medical University Hospital, Hirakata, Japan., Bando H; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Shiraishi Y; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan., Kobayashi M; Translational Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan., Goto H; Translational Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan., Sato A; Clinical Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan., Fujii S; Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Tokyo, Japan.; Department of Molecular Pathology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan., Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Nakamura Y; Translational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan.; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 13; Vol. 30 (18), pp. 4167-4178.
Autor:
Llombart-Cussac A; Arnau de Vilanova Hospital, Valencia, Spain.; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas and Co., Jersey City, New Jersey, Sao Paulo, Brazil., Pérez-García J; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas and Co., Jersey City, New Jersey, Sao Paulo, Brazil.; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain., Brasó-Maristany F; Reveal Genomics, S.L Barcelona, Barcelona, Spain.; Institut D'Investigacions Biomèdiques August Pi i Sunyer Barcelona, Barcelona, Spain., Paré L; Reveal Genomics, S.L Barcelona, Barcelona, Spain., Villacampa G; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Gion M; Hospital Universitario Ramón y Cajal, Madrid, Spain., Schmid P; Bart Cancer Institute, Queen Mary University of London, London, United Kingdom., Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy., Borrego MR; Hospital Universitario Virgen del Rocío, Sevilla, Spain., Galván P; Reveal Genomics, S.L Barcelona, Barcelona, Spain.; Institut D'Investigacions Biomèdiques August Pi i Sunyer Barcelona, Barcelona, Spain., Parker JS; Reveal Genomics, S.L Barcelona, Barcelona, Spain.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Buckingham W; Reveal Genomics, S.L Barcelona, Barcelona, Spain., Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Villagrasa P; Reveal Genomics, S.L Barcelona, Barcelona, Spain., Guerrero JA; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas and Co., Jersey City, New Jersey, Sao Paulo, Brazil., Sampayo-Cordero M; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas and Co., Jersey City, New Jersey, Sao Paulo, Brazil., Mancino M; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas and Co., Jersey City, New Jersey, Sao Paulo, Brazil., Prat A; Reveal Genomics, S.L Barcelona, Barcelona, Spain.; Institut D'Investigacions Biomèdiques August Pi i Sunyer Barcelona, Barcelona, Spain.; Cancer Institute and Blood Diseases, Hospital Clinic de Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Institute of Oncology (IOB)-Hospital Quirónsalud, Barcelona, Spain., Cortés J; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas and Co., Jersey City, New Jersey, Sao Paulo, Brazil.; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 13; Vol. 30 (18), pp. 4123-4130.
Autor:
Lian J; Department of Pathology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, China., Li RQ; Department of Pathology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, China., Yan L; Department of Pathology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, China., Bu P; Department of Pathology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, China., Wang HW; Department of Pathology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, China., Xi YF; Department of Pathology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, China.
Publikováno v:
Zhonghua bing li xue za zhi = Chinese journal of pathology [Zhonghua Bing Li Xue Za Zhi] 2024 Sep 08; Vol. 53 (9), pp. 898-904.
Autor:
Faizan S; Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Mysuru 570015, Constituent College of the JSS Academy of Higher Education & Research, Mysuru, 570015, India., Wali AF; Department of Pharmaceutical Chemistry, RAK College of Pharmacy, RAK Medical & Health Sciences University, Ras Al Khaimah, United Arab Emirates., Talath S; Department of Pharmaceutical Chemistry, RAK College of Pharmacy, RAK Medical & Health Sciences University, Ras Al Khaimah, United Arab Emirates., Rehman MU; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia., Sivamani Y; Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Mysuru 570015, Constituent College of the JSS Academy of Higher Education & Research, Mysuru, 570015, India., Nilugal KC; School of Pharmacy, Management and Science University, Selangor, 40100, Malaysia., Shivangere NB; School of Pharmacy, Management and Science University, Selangor, 40100, Malaysia., Attia SM; Department of Pharmacology & Toxicology, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia., Nadeem A; Department of Pharmacology & Toxicology, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia., Elayaperumal S; Department of Biotechnology and Bioinformatics, JSS Academy of Higher Education and Research, Mysore, Karnataka, India., Kumar BRP; Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Mysuru 570015, Constituent College of the JSS Academy of Higher Education & Research, Mysuru, 570015, India. Electronic address: brprashanthkumar@jssuni.edu.in.
Publikováno v:
European journal of medicinal chemistry [Eur J Med Chem] 2024 Sep 05; Vol. 275, pp. 116607. Date of Electronic Publication: 2024 Jun 19.
Autor:
Wang Y; Department of Pathology, Peking University First Hospital, Beijing 100034, China., Li X; Department of Pathology, Peking University First Hospital, Beijing 100034, China., Zhang S; Department of Pathology, Peking University First Hospital, Beijing 100034, China., Liang L; Department of Pathology, Peking University First Hospital, Beijing 100034, China., Xu L; Breast Disease Center, Peking University First Hospital, Beijing 100034, China., Liu Y; Breast Disease Center, Peking University First Hospital, Beijing 100034, China., Li T; Department of Pathology, Peking University First Hospital, Beijing 100034, China.
Publikováno v:
Japanese journal of clinical oncology [Jpn J Clin Oncol] 2024 Sep 04; Vol. 54 (9), pp. 1024-1031.